J2353

HCPCS

Octreotide injection, depot

Official HCPCS Level II long descriptor

Injection, octreotide, depot form for intramuscular injection, 1 mg

HCPCS Level II code J2353 is maintained by CMS and is active in the current quarterly release.

Short descriptor

Octreotide injection, depot

Added to HCPCS: 2004-01-01

Nearby codes in J2

J2320Nandrolone decanoate 50 mg
J2323Natalizumab injection
J2325Nesiritide injection
J2326Inj, nusinersen, 0.1mg
J2327Inj risankizumab-rzaa 1 mg
J2329Inj ublituximab-xiiy, 1 mg
J2350Injection, ocrelizumab, 1 mg
J2351Inj ocrelizumab 1mg hya-ocsq
J2354Octreotide inj, non-depot
J2355Oprelvekin injection
J2356Inj tezepelumab-ekko, 1mg
J2357Omalizumab injection
J2358Olanzapine long-acting inj
J2359Inj. olanzapine, 0.5mg
J2360Orphenadrine injection
J2361Inj depemokimab-ulaa 1 mg

Where this code sits

HCPCS Level II J2 codes

Krasyn AI Coder

Get code suggestions automatically as you type notes. Free for 50 analyses.

Install for Chrome — free

Source

HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.